Please assess the completion status of the following clinical trial:

Trial Title: Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Meet criteria for primary Fibromyalgia Syndrome as defined by the American College of Rheumatology~Exclusion Criteria:~* Have any current primary Axis I diagnosis other than major depressive disorder~* Have any current or previous diagnosis of psychosis, bipolar disorder, or schizoaffective disorder~* Have any primary diagnosis of anxiety disorder within the past year (including panic disorder, agoraphobia, OCD, PTSD, GAD and social phobia)~* Have regional pain syndrome, multiple surgeries or failed back syndrome~* Have a confirmed current or previous diagnosis of rheumatoid arthritis, inflammatory arthritis, or infective arthritis, or an autoimmune disease (e.g. lupus)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).